620 related articles for article (PubMed ID: 18703042)
1. Crotalphine induces potent antinociception in neuropathic pain by acting at peripheral opioid receptors.
Gutierrez VP; Konno K; Chacur M; Sampaio SC; Picolo G; Brigatte P; Zambelli VO; Cury Y
Eur J Pharmacol; 2008 Oct; 594(1-3):84-92. PubMed ID: 18703042
[TBL] [Abstract][Full Text] [Related]
2. Crotalphine, a novel potent analgesic peptide from the venom of the South American rattlesnake Crotalus durissus terrificus.
Konno K; Picolo G; Gutierrez VP; Brigatte P; Zambelli VO; Camargo AC; Cury Y
Peptides; 2008 Aug; 29(8):1293-304. PubMed ID: 18495297
[TBL] [Abstract][Full Text] [Related]
3. The peripheral L-arginine-nitric oxide-cyclic GMP pathway and ATP-sensitive K⁺ channels are involved in the antinociceptive effect of crotalphine on neuropathic pain in rats.
Gutierrez VP; Zambelli VO; Picolo G; Chacur M; Sampaio SC; Brigatte P; Konno K; Cury Y
Behav Pharmacol; 2012 Feb; 23(1):14-24. PubMed ID: 22126967
[TBL] [Abstract][Full Text] [Related]
4. The analgesic effect of crotoxin on neuropathic pain is mediated by central muscarinic receptors and 5-lipoxygenase-derived mediators.
Nogueira-Neto Fde S; Amorim RL; Brigatte P; Picolo G; Ferreira WA; Gutierrez VP; Conceição IM; Della-Casa MS; Takahira RK; Nicoletti JL; Cury Y
Pharmacol Biochem Behav; 2008 Dec; 91(2):252-60. PubMed ID: 18778727
[TBL] [Abstract][Full Text] [Related]
5. Peripheral kappa and delta opioid receptors are involved in the antinociceptive effect of crotalphine in a rat model of cancer pain.
Brigatte P; Konno K; Gutierrez VP; Sampaio SC; Zambelli VO; Picolo G; Curi R; Cury Y
Pharmacol Biochem Behav; 2013 Aug; 109():1-7. PubMed ID: 23628488
[TBL] [Abstract][Full Text] [Related]
6. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the antinociceptive effect of systemic administration of tramadol and dexmedetomidine combination on rat models of acute and neuropathic pain.
Guneli E; Karabay Yavasoglu NU; Apaydin S; Uyar M; Uyar M
Pharmacol Biochem Behav; 2007 Nov; 88(1):9-17. PubMed ID: 17651791
[TBL] [Abstract][Full Text] [Related]
8. Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injury-induced mechanical hypersensitivity.
Joshi SK; Hernandez G; Mikusa JP; Zhu CZ; Zhong C; Salyers A; Wismer CT; Chandran P; Decker MW; Honore P
Neuroscience; 2006 Dec; 143(2):587-96. PubMed ID: 16962719
[TBL] [Abstract][Full Text] [Related]
9. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive effect of the C-terminus of murine S100A9 protein on experimental neuropathic pain.
Paccola CC; Gutierrez VP; Longo I; Juliano L; Juliano MA; Giorgi R
Peptides; 2008 Oct; 29(10):1806-14. PubMed ID: 18582512
[TBL] [Abstract][Full Text] [Related]
11. Diphenyl diselenide attenuates acute thermal hyperalgesia and persistent inflammatory and neuropathic pain behavior in mice.
Savegnago L; Jesse CR; Pinto LG; Rocha JB; Nogueira CW
Brain Res; 2007 Oct; 1175():54-9. PubMed ID: 17888416
[TBL] [Abstract][Full Text] [Related]
12. Effect of etanercept, a tumor necrosis factor-alpha inhibitor, on neuropathic pain in the rat chronic constriction injury model.
Zanella JM; Burright EN; Hildebrand K; Hobot C; Cox M; Christoferson L; McKay WF
Spine (Phila Pa 1976); 2008 Feb; 33(3):227-34. PubMed ID: 18303453
[TBL] [Abstract][Full Text] [Related]
13. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.
Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM
J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948
[TBL] [Abstract][Full Text] [Related]
14. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat.
Honore P; Donnelly-Roberts D; Namovic MT; Hsieh G; Zhu CZ; Mikusa JP; Hernandez G; Zhong C; Gauvin DM; Chandran P; Harris R; Medrano AP; Carroll W; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
J Pharmacol Exp Ther; 2006 Dec; 319(3):1376-85. PubMed ID: 16982702
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization and gene expression profiling of an L5/L6 spinal nerve ligation model for neuropathic pain in mice.
Kiso T; Watabiki T; Tsukamoto M; Okabe M; Kagami M; Nishimura K; Aoki T; Matsuoka N
Neuroscience; 2008 May; 153(2):492-500. PubMed ID: 18400411
[TBL] [Abstract][Full Text] [Related]
16. Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice.
Benbouzid M; Choucair-Jaafar N; Yalcin I; Waltisperger E; Muller A; Freund-Mercier MJ; Barrot M
Eur J Pain; 2008 Nov; 12(8):1008-17. PubMed ID: 18331804
[TBL] [Abstract][Full Text] [Related]
17. Co-administration of MK-801 and morphine attenuates neuropathic pain in rat.
Hamidi GA; Manaheji H; Janahmadi M; Noorbakhsh SM; Salami M
Physiol Behav; 2006 Jul; 88(4-5):628-35. PubMed ID: 16815501
[TBL] [Abstract][Full Text] [Related]
18. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.
Holdridge SV; Cahill CM
Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of the chronic constriction injury model of neuropathic pain.
De Vry J; Kuhl E; Franken-Kunkel P; Eckel G
Eur J Pharmacol; 2004 May; 491(2-3):137-48. PubMed ID: 15140630
[TBL] [Abstract][Full Text] [Related]
20. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
